Tool: DupCheckTool: DupCheck is a web-based tool to screen for duplicate patients in clinical trials within and across studies, sponsors and therapeutic areas. Please visit our "Tools" page for more information.

Project FlyerProject Flyer

Click here to download 
the NEWMEDS project flyer! 

consortium teaser

Project Office Project Office Annual PGB and WP Leads Meetings Annual PGB and WP Leads Meetings Project Governance Project Governance Funding Mechanisms Funding Mechanisms

  Members Area

IMI | The Innovative Medicines Initiative
EFPIA | European Federation of Pharmaceutical Industries and Associations

The Group

Currently, the NEWMEDS project consists of 19 participating institutions based in nine different EU member states as well as in Iceland, Switzerland and Israel.
Nearly all major biopharmaceutical companies including AstraZeneca, Eli Lilly, Janssen Pharmaceutica, Lundbeck A/S, Novartis, Orion, Pfizer, Roche, Servier and Abbott are participating in the project. Academic institutions involved are: King’s College London, Karolinska Institutet (Stockholm), The University of Cambridge, Central Institute of Mental Health (Mannheim), CSIC (IIBB, Barcelona), the University of Manchester and the Bar Ilan University (Israel). Additionally, two pharmaceutical small and medium-sized enterprises, deCODE (Reykjavik) and Psynova (Cambridge) will contribute to the success of NEWMEDS, while the SME GABO:mi (Munich) is taking over administrative project management tasks.